Salient Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$3.16M
- Investors
-
4
Salient Bio General Information
Description
Operator of the diagnostic laboratory intended to broaden access to medical testing. The company integrates synthetic biology and robotics to create automated laboratory facilities offering a wide range of diagnostic services, including routine and specialized tests, alongside research and development in microbiome analysis, helping researchers and healthcare professionals with a focus on expanding the availability of diagnostic testing.
Contact Information
Website
www.salient.bioCorporate Office
- Unit 506, The Biscuit Factory
- 100 Drummond Road
- London SE16 4DG
- England, United Kingdom
Corporate Office
- Unit 506, The Biscuit Factory
- 100 Drummond Road
- London SE16 4DG
- England, United Kingdom
Salient Bio Timeline
Salient Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | 03-Sep-2025 | $3.16M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 01-May-2024 | Completed | Startup | |||
| 2. Seed Round | 10-Nov-2020 | $1.5M | $1.5M | Completed | Startup | |
| 1. Spin-Off | Completed | Startup |
Salient Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 356,262 | $0.000000 | $1.8 | $1.8 | 1x | $1.8 | 6.38% | |
| Ordinary | 637,504 | $0.000000 | $1.44 | $1.44 | 1x | $1.44 | 11.42% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Salient Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Salient Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Salient Bio Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| THENA Capital | Venture Capital | Minority | ||
| Vanneck | Venture Capital | Minority | ||
| WCS Nominees | Corporation | Minority | ||
| Grow London | Accelerator/Incubator |
Salient Bio FAQs
-
When was Salient Bio founded?
Salient Bio was founded in 2020.
-
Where is Salient Bio headquartered?
Salient Bio is headquartered in London, United Kingdom.
-
What is the size of Salient Bio?
Salient Bio has 21 total employees.
-
What industry is Salient Bio in?
Salient Bio’s primary industry is Laboratory Services (Healthcare).
-
Is Salient Bio a private or public company?
Salient Bio is a Private company.
-
What is the current valuation of Salient Bio?
The current valuation of Salient Bio is .
-
What is Salient Bio’s current revenue?
The current revenue for Salient Bio is .
-
How much funding has Salient Bio raised over time?
Salient Bio has raised $4.66M.
-
Who are Salient Bio’s investors?
THENA Capital, Vanneck, WCS Nominees, and Grow London have invested in Salient Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
